ReShape

ReShape is a California-based company that designs and manufactures minimally invasive medical devices for the treatment of obesity and metabolic diseases.

Business Model:

Revenue: $11.3M

Employees: 11-50

Detailed ReShape Information

ReShape was acquired by EnteroMedics.
The acquisition happend on 2017-10-03.
Details of the transaction were not public

Acquirer

Geographic Data

ReShape headquarters map

Address: 1001 Calle Amanecer

City: San Clemente

State: CA

Zip: 92673

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$46M

Raised Total:

$138M

Metrics

4,599,597Website Global Rank

2,000Website Monthly Traffic

Twitter Followers

Description

ReShape is a California-based company that designs and manufactures minimally invasive medical devices for the treatment of obesity and metabolic diseases.

Contact Phone:
+18449377374

Contact Email:

ReShape went public on 10/3/2007 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/3/2007

Ticker Symbol:
RSLS

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
8/2007 Series A 2 $3M SV Health Investors
New Leaf Venture Partners
SV Health Investors
New Leaf Venture Partners
2/2009 Post-IPO Equity 3 $20M U.S. Venture Partners
SV Health Investors
New Leaf Venture Partners
U.S. Venture Partners
SV Health Investors
New Leaf Venture Partners
6/2021 Post-IPO Equity $46M
9/2019 Post-IPO Equity $15.3M
7/2014 Post-IPO Debt $4M
6/2018 Post-IPO Equity $1.5M
7/2018 Post-IPO Equity $3M
6/2012 Post-IPO Equity $1.5M
10/2012 Post-IPO Equity 4 $15M Venture Investors
SV Health Investors
Venture Investors
U.S. Venture Partners
New Leaf Venture Partners
Venture Investors
SV Health Investors
Venture Investors
2/2015 Post-IPO Debt $6.8M
4/2018 Post-IPO Equity $6M
4/2015 Post-IPO Debt 2 $12M Oxford Finance LLC
Silicon Valley Bank
Oxford Finance LLC
Silicon Valley Bank
8/2015 Post-IPO Equity 6 $38M U.S. Venture Partners
HealthCor Partners
New Leaf Venture Partners
Venture Investors
SV Health Investors
Endeavour Vision
HealthCor Partners
U.S. Venture Partners
HealthCor Partners
New Leaf Venture Partners
Venture Investors
SV Health Investors
Endeavour Vision
HealthCor Partners
2/2023 Post-IPO Equity $10.2M
6/2018 Unattributed $1.5M
7/2018 Unattributed $2.8M
4/2020 Debt $350k U.S. Small Business Administration.
6/2019 Private Placement $8M
Announced Date Name Price
1/2021 Obalon Therapeutics

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research